Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 223 of 223 entries
View as:

Safety and PK Study of Ha44 Gel Under Maximal Use Conditions for Treatment of Head Lice Infestation

Phase: N/A Priority: Normal
NCT ID: NCT01907490 Org: User:
Start: 03/31/13 End: 12/31/13 Due: 12/31/14

Lamotrigine Extended-Release Tablets 50 mg Under Fed Condition

Phase: N/A Priority: Normal
NCT ID: NCT01888757 Org: User:
Start: 09/30/10 End: 10/31/10 Due: 10/31/11

Cetirizine Hydrochloride Tablets, 10 mg Bioequivalence Study of Dr.Reddy's Under Fasting Condition

Phase: N/A Priority: Normal
NCT ID: NCT01064102 Org: User:
Start: 01/31/06 End: 02/28/06 Due: 02/28/07

Bioequivalence Study of Divalproex Sodium Capsules(Sprinkle),125 mg of Dr. Reddy's Under Fasting Condition (Apple Sauce)

Phase: N/A Priority: Normal
NCT ID: NCT01132183 Org: User:
Start: 02/28/07 End: 03/31/07 Due: 03/31/08

Bioequivalence Study of Terbinafine Hydrochloride Tablets, 250 mg of Dr. Reddy's Under Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT01286688 Org: User:
Start: 01/31/02 End: 03/31/02 Due: 03/31/03

Bioequivalence Study of Isotretinoin Capsules 40 mg Under Fed Condition

Phase: N/A Priority: Normal
NCT ID: NCT01888328 Org: User:
Start: 05/31/01 End: 06/30/01 Due: 06/30/02

A Pediatric Safety and Pharmacokinetics Study of Ha44 Gel Administered Topically for Treatment of Head Lice Infestation

Phase: N/A Priority: Normal
NCT ID: NCT02010333 Org: User:
Start: 04/30/13 End: 08/31/14 Due: 08/31/15

Amtolmetin Gaucil in Knee Osteoarthritis

Phase: N/A Priority: Normal
NCT ID: NCT02865161 Org: User:
Start: 02/28/15 End: 12/31/15 Due: 12/31/16

Bioequivalence Study for Ondansetron Hydrochloride Tablets 8 mg Under Fed Condition

Phase: N/A Priority: Normal
NCT ID: NCT01511718 Org: User:
Start: 10/31/06 End: 10/31/06 Due: 10/31/07

Bioequivalence Study for Lamotrigine Tablets 200 mg Under Fasting Condition

Phase: N/A Priority: Normal
NCT ID: NCT01513720 Org: User:
Start: 12/31/02 End: 12/31/02 Due: 12/31/03

Bioequivalence Study for Desloratadine OD Tablets 5 mg Under Fed Condition

Phase: N/A Priority: Normal
NCT ID: NCT01506037 Org: User:
Start: 01/31/06 End: 02/28/06 Due: 02/28/07

Carvedilol 25 mg Film-coated Tablets, Bioequivalence Study of Dr. Reddys Under Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT01064154 Org: User:
Start: 05/31/02 End: 05/31/02 Due: 05/31/03

Bioequivalency Study of Amlodipine Besylate Tablets, 10 mg of Dr. Reddy's Under Fed Conditions

Phase: N/A Priority: Normal
NCT ID: NCT01131936 Org: User:
Start: 08/31/02 End: 11/30/02 Due: 11/30/03

Bioequivalence Study of Zonisamide Capsules 100 mg of Dr.Reddy's Laboratories Limited Under Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT01161966 Org: User:
Start: 01/31/05 End: 03/31/05 Due: 03/31/06

A Phase III Transition Study of DRL Rituximab to Reference Medicinal Products

Phase: N/A Priority: Normal
NCT ID: NCT04268771 Org: User:
Start: 04/08/20 End: 04/20/22 Due: 04/20/23

Study of the Efficacy and Safety of Abametapir Lotion Administered for the Treatment of Head Lice Infestation

Phase: N/A Priority: Normal
NCT ID: NCT02062060 Org: User:
Start: 02/28/14 End: 08/31/14 Due: 08/31/15

Bioequivalence Study of Lamotrigine Extended-Release Tablets 50 mg Under Fasting Condition

Phase: N/A Priority: Normal
NCT ID: NCT01888731 Org: User:
Start: 08/31/10 End: 09/30/10 Due: 09/30/11

Two Dose Levels of DFN-15 vs. Placebo in Patients With Migraine Headaches

Phase: N/A Priority: Normal
NCT ID: NCT02472418 Org: User:
Start: 06/05/15 End: 05/05/16 Due: 05/05/17

Bioequivalence Study of Ropinirole Hydrochloride ER Tablets 2 mg Under Fasting Condition

Phase: N/A Priority: Normal
NCT ID: NCT01627834 Org: User:
Start: 10/31/09 End: 11/30/09 Due: 11/30/10

Cetirizine Hydrochloride Tablets, 10 mg Bioequivalence Study of Dr.Reddy's Under Fed Condition

Phase: N/A Priority: Normal
NCT ID: NCT01064115 Org: User:
Start: 01/31/06 End: 02/28/06 Due: 02/28/07

Clinical Trial to Assess Safety and Immunogenicity of Gam-COVID-Vac Combined Vector Vaccine for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Сov-2) Infection

Phase: N/A Priority: Normal
NCT ID: NCT04640233 Org: User:
Start: 11/30/20 End: 09/30/21 Due: 09/30/22

Bioequivalence Study of Doxorubicin Hydrochloride Liposome Injection

Phase: N/A Priority: Normal
NCT ID: NCT02260544 Org: User:
Start: 07/31/14 End: 08/31/15 Due: 08/31/16

Levofloxacin as an Empirical Therapy in Patients With Complicated Urinary Tract Infections

Phase: N/A Priority: Normal
NCT ID: NCT03160807 Org: User:
Start: 04/15/17 End: 03/31/18 Due: 03/31/19